glp 1 liver disease glp-1 toxicity The future of incretins in the treatment of obesity and non-alcoholic fatty liver Multiple target tissue effects of

As in terrestrial mammals and birds, the liver was the most active tissue for GSH synthesis in HSB

How GLP-1/GIP dual agonists work for weight loss GLP-1/GIP dual agonists (or "co-agonists") mimic the actions of two peptide hormones, GLP-1 and GIP

doi: 10.1002/rcm.v23:5 176 LindbergGLarssonGSetterlindSRstamL

Controversial due to potential long-term toxicity concerns

further improved this treatment for pulmonary metastatic lung cancer, developing aminoethylanisamide-polyethylene glycol (AA-PEG) exosomes, which were loaded with PTX (AA-PEG-exoPTX), these exosomes exhibit a higher loading capacity and better anti-cancer effect in a mouse model [184]

NIH MedlinePlus